Annual Current Assets
$24.01 M
-$5.28 M-18.03%
March 1, 2024
Summary
- As of February 8, 2025, GRCE annual total current assets is $24.01 million, with the most recent change of -$5.28 million (-18.03%) on March 1, 2024.
- During the last 3 years, GRCE annual current assets has fallen by -$38.36 million (-61.51%).
- GRCE annual current assets is now -61.51% below its all-time high of $62.37 million, reached on March 1, 2021.
Performance
GRCE Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$16.06 M
-$4.37 M-21.38%
September 1, 2024
Summary
- As of February 8, 2025, GRCE quarterly total current assets is $16.06 million, with the most recent change of -$4.37 million (-21.38%) on September 1, 2024.
- Over the past year, GRCE quarterly current assets has dropped by -$10.82 million (-40.25%).
- GRCE quarterly current assets is now -74.25% below its all-time high of $62.37 million, reached on March 1, 2021.
Performance
GRCE Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
GRCE Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -18.0% | -40.3% |
| 3 y3 years | -61.5% | -57.2% |
| 5 y5 years | -14.2% | -23.4% |
GRCE Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -61.5% | at low | -67.2% | at low |
| 5 y | 5-year | -61.5% | +30.1% | -74.3% | +17.1% |
| alltime | all time | -61.5% | +2670.3% | -74.3% | +3112.4% |
Grace Therapeutics Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $16.06 M(-21.4%) |
| Jun 2024 | - | $20.43 M(-14.9%) |
| Mar 2024 | $49.29 M(-1.1%) | $24.01 M(-10.7%) |
| Dec 2023 | - | $26.88 M(-6.9%) |
| Sep 2023 | - | $28.89 M(+22.3%) |
| Jun 2023 | - | $23.61 M(-19.4%) |
| Mar 2023 | $49.83 M(-40.2%) | $29.29 M(-12.4%) |
| Dec 2022 | - | $33.43 M(-10.9%) |
| Sep 2022 | - | $37.51 M(-9.1%) |
| Jun 2022 | - | $41.25 M(-8.9%) |
| Mar 2022 | $83.34 M(>+9900.0%) | $45.28 M(-7.6%) |
| Dec 2021 | - | $49.00 M(-10.2%) |
| Sep 2021 | - | $54.55 M(-9.7%) |
| Jun 2021 | - | $60.39 M(-3.2%) |
| Mar 2021 | $86.00 K(-98.0%) | $62.37 M(+106.5%) |
| Dec 2020 | - | $30.20 M(+120.2%) |
| Sep 2020 | - | $13.71 M(-1.8%) |
| Jun 2020 | - | $13.96 M(-24.4%) |
| Mar 2020 | $4.39 M(-50.8%) | $18.46 M(-18.6%) |
| Dec 2019 | - | $22.67 M(+8.1%) |
| Sep 2019 | - | $20.98 M(-2.0%) |
| Jun 2019 | - | $21.41 M(-23.5%) |
| Mar 2019 | $8.93 M(-14.4%) | $27.97 M(-20.2%) |
| Dec 2018 | - | $35.05 M(+515.1%) |
| Sep 2018 | - | $5.70 M(-45.9%) |
| Jun 2018 | - | $10.52 M(+43.2%) |
| Mar 2018 | $10.43 M(-8.4%) | $7.35 M(-31.5%) |
| Dec 2017 | - | $10.73 M(+127.4%) |
| Sep 2017 | - | $4.72 M(-23.1%) |
| Jun 2017 | - | $6.14 M |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | $11.38 M(-10.3%) | - |
| Nov 2016 | - | $4.60 M(-29.4%) |
| Aug 2016 | - | $6.52 M(-1.7%) |
| May 2016 | - | $6.63 M(-20.7%) |
| Feb 2016 | $12.69 M(-9.6%) | $8.36 M(-24.4%) |
| Nov 2015 | - | $11.06 M(-10.8%) |
| Aug 2015 | - | $12.40 M(-14.4%) |
| May 2015 | - | $14.48 M(-7.8%) |
| Feb 2015 | $14.04 M(-21.2%) | $15.70 M(-13.8%) |
| Nov 2014 | - | $18.21 M(-12.6%) |
| Aug 2014 | - | $20.84 M(-8.0%) |
| May 2014 | - | $22.66 M(-2.4%) |
| Feb 2014 | $17.81 M(+188.9%) | $23.20 M(+363.7%) |
| Nov 2013 | - | $5.00 M(+4.2%) |
| Aug 2013 | - | $4.80 M(-4.1%) |
| May 2013 | - | $5.00 M(-12.6%) |
| Feb 2013 | $6.16 M(-10.8%) | $5.72 M(-15.2%) |
| Nov 2012 | - | $6.75 M(-5.7%) |
| Aug 2012 | - | $7.15 M(-12.3%) |
| May 2012 | - | $8.16 M(-8.4%) |
| Feb 2012 | $6.91 M(-10.3%) | $8.91 M(+20.1%) |
| Nov 2011 | - | $7.41 M(+150.8%) |
| Aug 2011 | - | $2.96 M(-5.9%) |
| May 2011 | - | $3.14 M(-6.6%) |
| Feb 2011 | $7.71 M(-4.0%) | $3.36 M(-5.4%) |
| Nov 2010 | - | $3.56 M(+611.6%) |
| Aug 2010 | - | $500.00 K(-22.2%) |
| May 2010 | - | $643.00 K(-25.8%) |
| Feb 2010 | $8.03 M | $866.70 K(-13.0%) |
| Nov 2009 | - | $995.80 K |
FAQ
- What is Grace Therapeutics annual total current assets?
- What is the all time high annual current assets for Grace Therapeutics?
- What is Grace Therapeutics annual current assets year-on-year change?
- What is Grace Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Grace Therapeutics?
- What is Grace Therapeutics quarterly current assets year-on-year change?
What is Grace Therapeutics annual total current assets?
The current annual current assets of GRCE is $24.01 M
What is the all time high annual current assets for Grace Therapeutics?
Grace Therapeutics all-time high annual total current assets is $62.37 M
What is Grace Therapeutics annual current assets year-on-year change?
Over the past year, GRCE annual total current assets has changed by -$5.28 M (-18.03%)
What is Grace Therapeutics quarterly total current assets?
The current quarterly current assets of GRCE is $16.06 M
What is the all time high quarterly current assets for Grace Therapeutics?
Grace Therapeutics all-time high quarterly total current assets is $62.37 M
What is Grace Therapeutics quarterly current assets year-on-year change?
Over the past year, GRCE quarterly total current assets has changed by -$10.82 M (-40.25%)